Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

843
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
843
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

269
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
269
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

225
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
225
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

377
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
377
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

369
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

316
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
316

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing migraine care and research through Telemedicine and telemonitoring: E-diary tracking and home EEG.

Computational and structural biotechnology journal·2025
Same author

Quantitative electroencephalography in cerebral amyloid angiopathy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2024
Same author

NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease.

Journal of neurology·2024
Same author

Sensitivity of the Boston criteria version 2.0 in Dutch-type hereditary cerebral amyloid angiopathy.

International journal of stroke : official journal of the International Stroke Society·2024
Same author

Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual-echo arterial spin labeling MRI study.

Headache·2024
Same author

Sex-specific metabolic profiling to explain the increased CVD risk in women with migraine: a narrative review.

The journal of headache and pain·2023
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Employment of safety net enclosures].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The power of a neurodiversity perspective; demedicalizing mental health support].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.8K

[Medication-overuse headache].

J A Pijpers1, N J Wiendels, H Koppen

  • 1Leids Universitair Medisch Centrum, afd. Neurologie, Leiden.

Nederlands Tijdschrift Voor Geneeskunde
|January 20, 2018
PubMed
Summary
This summary is machine-generated.

Medication-overuse headache (MOH) is common and debilitating. Abruptly stopping acute headache drugs, with patient education, is the preferred treatment for this condition.

More Related Videos

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research
04:37

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research

Published on: March 1, 2024

1.4K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.9K

Related Experiment Videos

Last Updated: Feb 15, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.8K
Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research
04:37

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research

Published on: March 1, 2024

1.4K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.9K

Area of Science:

  • Neurology
  • Headache Medicine
  • Clinical Pharmacology

Background:

  • Medication-overuse headache (MOH) is a prevalent neurological disorder significantly impacting patient quality of life.
  • MOH is characterized by headaches occurring on 15 or more days per month due to the frequent use of acute headache medications for over three months.
  • The primary headache disorders underlying MOH are typically migraine or tension-type headache.

Purpose of the Study:

  • To define medication-overuse headache (MOH) and its diagnostic criteria.
  • To explore the potential pathomechanisms, including central sensitization, involved in MOH.
  • To outline the recommended initial treatment strategy for MOH, emphasizing detoxification.

Main Methods:

  • Defining MOH based on headache frequency and medication overuse criteria (simple analgesics ≥15 days/month; triptans/combinations ≥10 days/month).
  • Discussing the concept of central sensitization as a potential mechanism.
  • Describing the preferred detoxification method: abrupt, outpatient withdrawal of acute medications and caffeine.

Main Results:

  • Established clear diagnostic criteria for MOH based on headache frequency and medication use.
  • Highlighted central sensitization as a contributing factor to MOH.
  • Identified patient education as crucial for successful detoxification outcomes.

Conclusions:

  • Medication-overuse headache is a significant clinical challenge requiring specific management strategies.
  • Abrupt withdrawal of overused acute headache medications, coupled with comprehensive patient education, is the recommended initial treatment approach.
  • Understanding the underlying mechanisms and patient education are key to managing MOH effectively.